For the first time, scientists have answered a longstanding question in cell biology about a partnership of proteins called ...
Scientists at Nagoya University in Japan have identified the genes that allow an organism to switch between living as single ...
UGC NET Paper 1 Syllabus 2025: Are you aiming for the UGC NET Exam? You must start your preparation by checking the syllabus and pattern. It highlights all the important topics and areas. The best ...
This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...
Most mergers are engineered for efficiency. Systems are aligned, redundancies eliminated, and structures combined. Yet despite careful planning, most mergers fail to deliver on their strategic promise ...
The Pennsylvania site, shorthand for the dangers of nuclear power after a 1979 meltdown, is set for revival under a deal to power Microsoft data centers. By Qasim Nauman The Trump administration is ...
Among pollsters familiar with the American Jewish vote, the events of Nov. 4, 2025, in New York City will go down as Opposite Day. A CNN exit poll showed that Zohran Mamdani, the new mayor-elect, ...
Exploring biology in its native environment is perhaps the ideal scenario for generating better hypotheses about the cellular interactions that influence—and drive—healthy and diseased states, ...
IRS is developing a new Schedule 1-A to use to claim new deductions for tip income, overtime pay, car loan interest and new tax break for those 65 an older. IRS and Treasury give new guidance on what ...
With years of impactful experiences in the halls of power to his credit – despite, he admits, running for but never winning an elected office higher than UF student government treasurer – the head of ...
Brené Brown, a research professor at the University of Houston, delivered a TED Talk in 2010 on the power of vulnerability that’s since been viewed nearly 70 million times, making her a self-help guru ...
In an Aug. 7 earnings call, Eli Lilly CEO David Ricks told investors that the company plans to submit the drug, orforglipron, to the FDA for approval by the end of the year. Dan Skovronsky, chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results